Adriana Garibay-Escobar

Dr. Adriana Garibay-Escobar

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 October 2023 in Animals
Verified
Journal Article
Open access
PDF file
EVEliza Vazquez
Eliza Vazquez
YLYulia Lipovka
Yulia Lipovka
AAAlejandro Cervantes Arias
Alejandro Cervantes Arias
AGAdriana Garibay-Escobar
Adriana Garibay-Escobar
MHMichelle Haby
Michelle Haby
CVCarlos Velazquez
Carlos Velazquez
Mammary cancer is the most frequently diagnosed neoplasia in women and non-spayed female dogs and is one of the leading causes of death in both species. Canines develop spontaneous mammary tumors that share a significant number of biological, clinical, pathological and molecular characteristics with human breast cancers. This review provides a detailed description of the histological, molecular and clinical aspects of mammary cancer in canines; it discusses risk factors and currently available diagnostic and treatment options, as well as remaining challenges and unanswered questions. The incidence of mammary tumors is highly variable and is impacted by biological, pathological, cultural and socioeconomic factors, including hormonal status, breed, advanced age, obesity and diet. Diagnosis is mainly based on histopathology, although several efforts have been made to establish a molecular classification of canine mammary tumors to widen the spectrum of treatment options, which today rely heavily on surgical removal of tumors. Lastly, standardization of clinical study protocols, development of canine-specific biological tools, establishment of adequate dog-specific disease biomarkers and identification of targets for the development of new therapies that could improve survival and have less adverse effects than chemotherapy are among the remaining challenges.

1 June 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MMMayra A. Mendez-Encinas
Mayra A. Mendez-Encinas
DVDora E. Valencia-Rivera
Dora E. Valencia-Rivera
Jesus Ortega-GarcíaJesus Ortega-García
Jesus Ortega-García
Elizabeth Carvajal-MillanElizabeth Carvajal-Millan
Elizabeth Carvajal-Millan
JDJosé C. Díaz-Ríos
José C. Díaz-Ríos
CVCarlos Velazquez
Carlos Velazquez
Biological properties of Sonoran propolis (SP) are influenced by harvest time. Caborca propolis showed cellular protective capacity against reactive oxygen species, which might be implicated in anti-inflammatory effects. However, the anti-inflammatory activity of SP has not been investigated so far. This study investigated the anti-inflammatory activity of previously characterized seasonal SP extracts (SPE) and some of their main constituents (SPC). The anti-inflammatory activity of SPE and SPC was evaluated by measuring nitric oxide (NO) production, protein denaturation inhibition, heat-induced hemolysis inhibition, and hypotonicity-induced hemolysis inhibition. SPE from spring, autumn, and winter showed a higher cytotoxic effect on RAW 264.7 cells (IC50: 26.6 to 30.2 µg/mL) compared with summer extract (IC50: 49.4 µg/mL). SPE from spring reduced the NO secretion to basal levels at the lowest concentration tested (5 µg/mL). SPE inhibited the protein denaturation by 79% to 100%, and autumn showed the highest inhibitory activity. SPE stabilized erythrocyte membrane against heat-induced and hypotonicity-induced hemolysis in a concentration-dependent manner. Results indicate that the flavonoids chrysin, galangin, and pinocembrin could contribute to the anti-inflammatory activity of SPE and that the harvest time influences such a property. This study presents evidence of SPE pharmacological potential and some of their constituents.

21 April 2021 in Biofouling
Verified
Journal Article
Closed access
ENEsmeralda Ivonne Niño-Padilla
Esmeralda Ivonne Niño-Padilla
CVCarlos Velazquez
Carlos Velazquez
AGAdriana Garibay-Escobar
Adriana Garibay-Escobar
The role of biofilms in pathogenicity and treatment strategies is often neglected in mycobacterial infections. In recent years, the emergence of nontuberculous mycobacterial infections has necessitated the development of novel prophylactic strategies and elucidation of the mechanisms underlying the establishment of chronic infections. More importantly, the question arises whether members of the Mycobacterium tuberculosis complex can form biofilms and contribute to latent tuberculosis and drug resistance because of the long-lasting and recalcitrant nature of its infections. This review discusses some of the molecular mechanisms by which biofilms could play a role in infection or pathological events in humans. Graphical Abstract

1 September 2020 in Expert Review of Vaccines
Verified
Journal Article
Closed access
DODavid Ortega-Tirado
David Ortega-Tirado
AAAldo A. Arvizu-Flores
Aldo A. Arvizu-Flores
CVCarlos Velazquez
Carlos Velazquez
AGAdriana Garibay-Escobar
Adriana Garibay-Escobar
Tuberculosis (TB) is a major health problem worldwide. The BCG, the only authorized vaccine to fight TB, shows a variable protection in the adult population highlighting the need of a new vaccine. ...

17 December 2020 in Antioxidants
Verified
Journal Article
Open access
PDF file
Pablo Mendez-PfeifferPablo Mendez-Pfeiffer
Pablo Mendez-Pfeiffer
EAEfrain Alday
Efrain Alday
ACAna Laura Carreño
Ana Laura Carreño
JHJorge Hernández-Tánori
Jorge Hernández-Tánori
BMBeatriz Montaño-Leyva
Beatriz Montaño-Leyva
CVCarlos Velazquez
Carlos Velazquez
The main chemical composition and pharmacological potential of propolis from arid and semi-arid regions of the Sonoran Desert have been previously reported. Caborca propolis (CP), from an arid zone of the Sonoran Desert, has shown a polyphenolic profile that suggests a mixed plant origin, presenting poplar-type markers, as well as a 6-methoxylated flavonoid, xanthomicrol, characteristic of Asteraceae plants. In addition, CP has shown significant antioxidant properties and antiproliferative activity on cancer cells. In this study, we analyzed the influence of collection time on the chemical constitution, antiproliferative activity and protective capacity of CP against reactive oxygen species (ROS), by using HPLC–UV–diode array detection (DAD) analysis, 3-(4,5-dimethylthiazol-2-yl)-2,5-Dimethyltetrazoliumbromide (MTT) and 2,2-diphenyl-1-picryl-hydrazyl (DPPH) assays, as well as cellular antioxidant activity (CAA) assay on murine B-cell lymphoma M12.C3.F6 cells. HPLC–UV–DAD analyses of seasonally collected CP (one-year period) revealed quantitative differences among the most abundant CP constituents: pinocembrin, galangin, chrysin and pinobanksin-3-O-acetate. Though all seasonal samples of CP induced an antiproliferative effect in M12.C3.F6 cells, CP from autumn showed the highest inhibitory activity (IC50: 5.9 ± 0.6 µg/mL). The DPPH assay pointed out that CP collected in autumn presented the highest antioxidant potential (IC50: 58.8 ± 6.7 µg/mL), followed by winter (65.7 ± 12.2 µg/mL) and spring (67.0 ± 7.5 µg/mL); meanwhile, the summer sample showed a lesser antioxidant capacity (IC50: 98.7 ± 2.5 µg/mL). The CAA assay demonstrated that CP induced a significant protective effect against ROS production elicited by H2O2 in M12.C3.F6 cells. Pretreatment of M12.C3.F6 cells with CP from spring and autumn (25 and 50 µg/mL for 1 h) showed the highest reduction in intracellular ROS induced by H2O2 (1 and 5 mM). These results indicate that the antiproliferative effect and cellular antioxidant activity of CP are modulated by quantitative fluctuations in its polyphenolic profile due to its collection time.

1 September 2020 in Molecular Immunology
Verified
Journal Article
Closed access
DODavid Ortega-Tirado
David Ortega-Tirado
ENEsmeralda Ivonne Niño-Padilla
Esmeralda Ivonne Niño-Padilla
AAAldo A. Arvizu-Flores
Aldo A. Arvizu-Flores
CVCarlos Velazquez
Carlos Velazquez
CEClara Espitia
Clara Espitia
AGAdriana Garibay-Escobar
Adriana Garibay-Escobar